Armata Pharmaceuticals (ARMP) Cash & Current Investments (2016 - 2018)
Historic Cash & Current Investments for Armata Pharmaceuticals (ARMP) over the last 6 years, with Q3 2018 value amounting to $13.4 million.
- Armata Pharmaceuticals' Cash & Current Investments rose 7337.22% to $13.4 million in Q3 2018 from the same period last year, while for Sep 2018 it was $13.4 million, marking a year-over-year increase of 7337.22%. This contributed to the annual value of $5.1 million for FY2017, which is 0.0% changed from last year.
- Per Armata Pharmaceuticals' latest filing, its Cash & Current Investments stood at $13.4 million for Q3 2018, which was up 7337.22% from $15.4 million recorded in Q2 2018.
- In the past 5 years, Armata Pharmaceuticals' Cash & Current Investments registered a high of $16.6 million during Q1 2015, and its lowest value of $2.2 million during Q1 2017.
- Moreover, its 5-year median value for Cash & Current Investments was $9.0 million (2017), whereas its average is $9.5 million.
- The largest annual percentage gain for Armata Pharmaceuticals' Cash & Current Investments in the last 5 years was 218581.36% (2014), contrasted with its biggest fall of 6766.89% (2014).
- Quarter analysis of 5 years shows Armata Pharmaceuticals' Cash & Current Investments stood at $6.6 million in 2014, then skyrocketed by 42.38% to $9.4 million in 2015, then plummeted by 45.23% to $5.1 million in 2016, then changed by 0.0% to $5.1 million in 2017, then surged by 160.97% to $13.4 million in 2018.
- Its Cash & Current Investments was $13.4 million in Q3 2018, compared to $15.4 million in Q2 2018 and $8.2 million in Q1 2018.